Related Experiment Video
Updated: Jul 31, 2026

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Management of thyroid carcinosarcoma
S S al-Sobhi1, F Novosolov, U Sabançi
1UCSF/Mount Zion Medical Center 94143-1674, USA.
Surgery
|October 6, 1997
Summary
Thyroid carcinosarcoma is a rare, aggressive cancer. Most patients die within months, similar to anaplastic thyroid carcinoma, despite treatment.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Thyroid carcinosarcoma is a rare malignant tumor with limited clinical data.
- Understanding its behavior is crucial for patient management.
Observation:
- A retrospective analysis of 17 thyroid carcinosarcoma cases was performed.
- Patient ages ranged from 52 to 80 years, with a mean of 60 years.
- Treatment included partial or total thyroidectomy.
Findings:
- The mean survival was 5 months, with 71% of patients dying within 3 months.
- Lymph node or distant metastases were observed in 6 out of 7 autopsy cases.
- Thyroid carcinosarcoma exhibits aggressive behavior and a poor prognosis.
Implications:
- Thyroid carcinosarcoma clinical behavior mirrors that of anaplastic thyroid carcinoma.
- Aggressive multimodal treatment offers limited survival benefits.
- Potential risk factors include exposure to raw phosphorus, radiation, and chemotherapy agents.
More Related Videos
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023